Emma Ivansson
Overview
Explore the profile of Emma Ivansson including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
15
Citations
314
Followers
0
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Ivansson E, Hedlund Lindberg J, Stalberg K, Sundfeldt K, Gyllensten U, Enroth S
Sci Rep
. 2024 Jul;
14(1):17288.
PMID: 39068297
Ovarian cancer is the 8th most common cancer among women and has a 5-year survival of only 30-50%. While the survival is close to 90% for stage I tumours it...
2.
Hedlund Lindberg J, Widgren A, Ivansson E, Gustavsson I, Stalberg K, Gyllensten U, et al.
iScience
. 2024 Feb;
27(2):109001.
PMID: 38352226
Early detection is key for increased survival in ovarian cancer, but no general screening program exists today due to lack of biomarkers and overall cost versus benefit over traditional clinical...
3.
Rask-Andersen M, Ivansson E, Hoglund J, Ek W, Karlsson T, Johansson A
Cancer Cell
. 2023 Jun;
41(6):1186-1197.e4.
PMID: 37311415
Obesity is associated with several types of cancer and fat distribution, which differs dramatically between sexes, has been suggested to be an independent risk factor. However, sex-specific effects on cancer...
4.
Enroth S, Ivansson E, Hedlund Lindberg J, Lycke M, Bergman J, Reneland A, et al.
Commun Med (Lond)
. 2022 Oct;
2:124.
PMID: 36196264
Background: Ovarian cancer is the eighth most common cancer among women and due to late detection prognosis is poor with an overall 5-year survival of 30-50%. Novel biomarkers are needed...
5.
Gyllensten U, Hedlund-Lindberg J, Svensson J, Manninen J, Ost T, Ramsell J, et al.
Cancers (Basel)
. 2022 Apr;
14(7).
PMID: 35406529
Background: Ovarian cancer is the eighth most common cancer among women and has a 5-year survival of only 30-50%. The survival is close to 90% for patients in stage I...
6.
Genome-Wide Analyses for Osteosarcoma in Leonberger Dogs Reveal the Gene Locus as a Major Risk Locus
Letko A, Minor K, Norton E, Marinescu V, Drogemuller M, Ivansson E, et al.
Genes (Basel)
. 2021 Dec;
12(12).
PMID: 34946912
Dogs represent a unique spontaneous cancer model. Osteosarcoma (OSA) is the most common primary bone tumor in dogs (OMIA 001441-9615), and strongly resembles human forms of OSA. Several large- to...
7.
Spjuth O, Karlsson A, Clements M, Humphreys K, Ivansson E, Dowling J, et al.
J Am Med Inform Assoc
. 2017 Apr;
24(5):950-957.
PMID: 28444384
Objective: We provide an e-Science perspective on the workflow from risk factor discovery and classification of disease to evaluation of personalized intervention programs. As case studies, we use personalized prostate...
8.
Rantalainen M, Klevebring D, Lindberg J, Ivansson E, Rosin G, Kis L, et al.
Sci Rep
. 2016 Dec;
6:38037.
PMID: 27901097
Sequencing-based breast cancer diagnostics have the potential to replace routine biomarkers and provide molecular characterization that enable personalized precision medicine. Here we investigate the concordance between sequencing-based and routine diagnostic...
9.
Li J, Ivansson E, Klevebring D, Tobin N, Lindstrom L, Holm J, et al.
Clin Cancer Res
. 2016 Sep;
23(10):2584-2592.
PMID: 27587435
Interval breast cancer is of clinical interest, as it exhibits an aggressive phenotype and evades detection by screening mammography. A comprehensive picture of somatic changes that drive tumors to become...
10.
Brand J, Li J, Humphreys K, Karlsson R, Eriksson M, Ivansson E, et al.
Breast Cancer Res
. 2015 Jun;
17:75.
PMID: 26036842
Introduction: Mammographic density (MD) is a strong heritable and intermediate phenotype for breast cancer, but much of its genetic variation remains unexplained. We performed a large-scale genetic association study including...